Growth factors released into the coronary circulation after vascular injury promote proliferation of human vascular smooth muscle cells in culture.

[1]  L. Horwitz,et al.  Multiple growth factors are released from mechanically injured vascular smooth muscle cells. , 1995, The American journal of physiology.

[2]  S M Schwartz,et al.  The intima. Soil for atherosclerosis and restenosis. , 1995, Circulation research.

[3]  S. de Servi,et al.  Trapidil (Triazolopyrimidine), a Platelet‐Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results of the Randomized, Double‐Blind STARC Study , 1994, Circulation.

[4]  P. Dicorleto,et al.  Stable expression of human platelet-derived growth factor B chain by bovine aortic endothelial cells. Matrix association and selective proteolytic cleavage by thrombin. , 1994, The Journal of biological chemistry.

[5]  M. Condorelli,et al.  Local effect of serotonin released during coronary angioplasty. , 1994, The New England journal of medicine.

[6]  D. Crossman,et al.  Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. , 1993, Cardiovascular Research.

[7]  M. Sleigh,et al.  Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix , 1993, The Journal of cell biology.

[8]  P. Teirstein,et al.  Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  N. Olson,et al.  Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. , 1992, The Journal of clinical investigation.

[10]  L. Khachigian,et al.  A tyrosinated peptide representing the alternatively spliced exon of the platelet-derived growth factor A-chain binds specifically to cultured cells and interferes with binding of several growth factors. , 1992, The Journal of biological chemistry.

[11]  R. Ross,et al.  Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences , 1992, The Journal of cell biology.

[12]  M. Reidy,et al.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.

[13]  M. Reidy,et al.  Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Robinson,et al.  Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit. , 1990, Circulation.

[15]  J. Simpson,et al.  Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study. , 1990, Journal of the American College of Cardiology.

[16]  Kathleen M. Smith,et al.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.

[17]  K. Kent.  Restenosis after percutaneous transluminal coronary angioplasty. , 1988, The American journal of cardiology.

[18]  T. Barrett,et al.  Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Fleisher,et al.  Effect of heparin bonding on catheter-induced fibrin formation and platelet activation. , 1984, Circulation.

[20]  R E Vlietstra,et al.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.

[21]  P. Dartsch,et al.  Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions. , 1990, Arteriosclerosis.

[22]  M. Nobuyoshi,et al.  Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. , 1988, Journal of the American College of Cardiology.